After concluding the project, the company has achieved
a clear understanding of the FDA requirements for the
Pre-market submission and they get the Pre-market
submission approval.
About this Case Study
The case study involved verifying GMP compliance in an IVD company to enable the commercialisation of their products in the USA.
A mock inspection was conducted based on 21 CFR 820 requirements, customized to the company’s IVD products and processes.
To learn more about the successful project and the comprehensive results achieved in verifying GMP compliance for the IVD company, download the full case study now.
Discover the step-by-step process, key improvements, and valuable insights that led to FDA pre-market submission approval
Download the Case Study
View other our other resources and company news
Article Maintaining Data Integrity with Digital Validation
The importance of data integrity is a widely discussed issue. There has been a rise in regulatory bodies like the FDA and WHO auditors focusing ...
Read More
Blog Shaping the Future of Femtech to Inspire Inclusion and Innovation
On International Women’s Day, it’s crucial to shed light on the ongoing gap in women’s health equity and the pressing need for further support.
Read More
Article 3PARL® Consortium grows stronger with Qualandre’s emphasis on ethical conduct and trustworthiness
3PARL® consortium welcomes Owlpharma, embracing their enthusiastic commitment to shaping auditing excellence.
Read More
Blog Innovative Solutions for Cancer Diagnosis and Prevention
As we navigate the complexities of cancer care, there’s a shared commitment to driving change and ensuring equitable access to life-saving treatments. This year’s World ...
Read More
Article Owlpharma joins 3PARL® to propel mission for ethical GMP supply chains in Life Sciences
3PARL® consortium welcomes Owlpharma, embracing their enthusiastic commitment to shaping auditing excellence.
Read More
GxP Consultancy Decoding the technological minefield – A tactical approach to maximising Life Sciences R&D Software implementations
Navigating the intricate landscape of implementing systems in Life Sciences Quality & R&D requires a strategic approach to the end-to-end
Read More
Blog All change for computer software assurance in Life Sciences
Newly published FDA guidance on Computer Software Assurance (CSA), together with the second edition of the GAMP 5 guide, have shifted the emphasis away from ...
Read More
Article Pharma Audit among newest members of the recently launched initiative 3PARL®
3PARL® consortium welcomes Pharma Audit in its mission to assure consistent high standard of GMP supply chain audits in the life sciences industry Stevenage, ...
Read More
Blog Navigating ICH E6 (R3) changes for GCP excellence with a digitalised QMS process
In the realm of clinical research, adhering to Good Clinical Practice (GCP) through the ICH E6 guidelines has become an essential part for global compliance. ...
Read More